EE481 Cost-Effectiveness Analysis of Upadacitinib in Patients with Moderately to Severely Active Ulcerative Colitis in Greece
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.747
https://www.valueinhealthjournal.com/article/S1098-3015(23)03877-9/fulltext
Title :
EE481 Cost-Effectiveness Analysis of Upadacitinib in Patients with Moderately to Severely Active Ulcerative Colitis in Greece
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03877-9&doi=10.1016/j.jval.2023.09.747
First page :
Section Title :
Open access? :
No
Section Order :
10237